Endobiliary radiofrequency ablation in recurrence and unresectable cholangiocarcinoma

Phase 3

Recruiting

• Conditions: Advance Cholangiocarcinoma; &#45

• Registration Number: TCTR20190704002
• Lead Sponsor: Khon Kaen University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-04
• Study Completion: 2020-04-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

1. Age 18-75 years old.
2. Unresectable or recurrent cholangiocarcinoma diagnosis by pathology or radiographic.
3. Obstrucvtive jaundice (Total bilirubin > 3 mg/dl.)
4. Aviable for ERCP and Percutaneous procedure.

Exclusion Criteria

1.Massive ascites.
2.Uncorrectable coagulopathy.
3.Presence of main portal vein thrombosis.
4.Prior SEMS placement.
5.Child-Pugh Score C cirrhosis.
6.Pregnancy.
7.Performance status ECOG ≥ 3 (confined to bed / chair > 50% waking hours).
8.Presence of other malignancy.
9.Life expectancy < 3months.
10.Patients with cardiac pacemakers or other active implants.
11.Comorbidities : Congestive heart failure, COPD, Sepsis
12.Uncorrectable Thrombocytopenia (less than 100,000 /mm3), Uncorrectable Conagulopathy (INR > 1.5)

Study & Design

• Study Type: Interventional
• Study Design: Not specified